Apply for Cancer Control Grants

The Division of Cancer Control and Population Sciences funds a large portfolio of grants and contracts. The portfolio currently includes over 700 grants, valued at nearly $440 million. Here we provide a listing of funding opportunities that are currently accepting applications. Please visit this page regularly as new funding opportunities are added upon approval by NCI.

For information on the portfolio of over 700 grants, please go to Research Portfolios section of this website.


Filters

Show/Hide Filters
Research Categories
Type of Funding
Activity Code
Type of Research
Title Announcement # / Mechanism(s) Activity Code Clinical Research Expiration Date Program Contact Research Categories Type of Research
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes PAR-20-211 K18 No Independent Clinical Trials October 20, 2020 Gina Tesauro
240-276-6786
gina.tesauro@nih.gov
Basic Biobehavioral and Psychological Sciences Not Clinical Trials
Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents RFA-DA-21-009 R01 Clinical Trials Optional October 20, 2020 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Tobacco Control Research Clinical Trials
Improving Smoking Cessation Interventions among People Living with HIV RFA-CA-20-035 R01 Clinical Trials Optional September 5, 2020 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Tobacco Control Research Clinical Trials
Improving Smoking Cessation Interventions among People Living with HIV RFA-CA-20-036 R21 Clinical Trials Optional September 5, 2020 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Tobacco Control Research Clinical Trials
Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence RFA-CA-20-038 U54 Clinical Trials Optional July 23, 2020 Juli Klemm
301.480.5778
klemmj@mail.nih.gov

Samantha Finstad
240.276.6460
Samantha.Finstad@nih.gov
Cancer Survivorship, Epidemiology and Genomics Research, Health Behaviors Research, Surveillance Research Clinical Trials
Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences RFA-CA-20-039 U01 Clinical Trial Optional July 23, 2020 Juli Klemm
301.480.5778
klemmj@mail.nih.gov

Samantha Finstad
240.276.6460
Samantha.Finstad@nih.gov
Cancer Survivorship, Epidemiology and Genomics Research, Health Behaviors Research, Surveillance Research Clinical Trials
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes PAR-20-226 K18 Basic Experimental Studies with Humans Required March 18, 2023 Gina Tesauro
240-276-6786
gina.tesauro@nih.gov
Basic Biobehavioral and Psychological Sciences Clinical Trials
Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions NOT-OD-20-106 September 26, 2022 Susan Czajkowski
240-276-5871
Susan.Czajkowski@nih.gov
Health Behaviors Research
Notice of NCI's Participation on PAR-19-368, Accelerating the Pace of Drug Abuse Research Using Existing Data NOT-CA-20-061 R01 Clinical Trial Optional September 8, 2021 Carolyn Reyes-Guzman
240-276-7244
carolyn.reyes-guzman@nih.gov
Tobacco Control Research, Basic Biobehavioral and Psychological Sciences, Health Behaviors Research Clinical Trials
Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity PAR-20-179 R01 Clinical Trial Optional September 8, 2023 Bryan Kim
240-276-6669
bryan.kim@nih.gov
Healthcare Delivery Research, Basic Biobehavioral and Psychological Sciences Clinical Trials
Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences PAR-20-180 R01 Clinical Trial Optional September 8, 2023 Bryan Kim
240-276-6669
bryan.kim@nih.gov
Healthcare Delivery Research, Basic Biobehavioral and Psychological Sciences Clinical Trials
Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry – Study Sites and Coordinating Center RFA-HG-20-001 U01 Clinical Trial Not Allowed June 24, 2020 Damali N. Martin
240-276-6746
martinda@mail.nih.gov
Epidemiology and Genomics Research, Health Disparities Not Clinical Trials
Utilizing Cohort Studies to Address Health Outcomes in Cancer Survivors RFA-CA-20-030 UG3/UH3 Clinical Trial Not Allowed July 8, 2020 Joanne Elena
240-276-6818
joanne.elena@nih.gov
Epidemiology and Genomics Research, Healthcare Delivery Research, Cancer Survivorship Not Clinical Trials
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) PA-20-172 R01 Clinical Trial Optional September 8, 2023 Sallie J. Weaver
(240) 276-6254
sallie.weaver@nih.gov
Health Disparities, Healthcare Delivery Research  
Notice to Extend the Expiration Date for PA-17-132 "Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R21)" NOT-AA-20-008     September 8, 2020 Carolyn Reyes-Guzman
240-276-7244
carolyn.reyes-guzman@nih.gov
Basic Biobehavioral and Psychological Sciences, Tobacco Control Research, Implementation Science  
Notice to Extend the Expiration Date for PA-17-132 "Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R03)" NOT-AA-20-009     September 8, 2020 Carolyn Reyes-Guzman
240-276-7244
carolyn.reyes-guzman@nih.gov
Basic Biobehavioral and Psychological Sciences, Tobacco Control Research, Implementation Science  
Notice to Extend the Expiration Date for PA-17-132 "Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R01)" NOT-AA-20-010     September 8, 2020 Carolyn Reyes-Guzman
240-276-7244
carolyn.reyes-guzman@nih.gov
Basic Biobehavioral and Psychological Sciences, Tobacco Control Research, Implementation Science  
Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) NOT-CA-20-042     June 26, 2020 Steve White
whitest@mail.nih.gov
Epidemiology and Genomics Research, Healthcare Delivery Research, Implementation Science  
Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19) NOT-CA-20-043     June 26, 2020 Ashim Subedee
240-276-7601
ashim.subedee@nih.gov
Epidemiology and Genomics Research, Healthcare Delivery Research, Implementation Science  
Integrative Research on Polysubstance Abuse and Disorder PAR-20-035 R61/R33 Clinical Trial Optional November 8, 2022 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov

David Berrigan
240-276-6752
berrigad@nih.gov
Tobacco Control Research, Health Behaviors Research Clinical Trials
Notice of Special Interest (NOSI) Research to Advance the Understanding of Tobacco Product Pharmacokinetic Research NOT-OD-20-081     February 13, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Tobacco Control Research  
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors RFA-CA-20-027 R01 Clinical Trial Optional July 31, 2021 Michelle Mollica
240-276-7621
michelle.mollica@nih.gov

Danielle Daee
240-276-5744
danielle.daee@nih.gov
Epidemiology and Genomics Research, Healthcare Delivery Research, Cancer Survivorship Clinical Trials
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors RFA-CA-20-028 R21 Clinical Trial Optional July 31, 2021 Michelle Mollica
240-276-7621
michelle.mollica@nih.gov

Danielle Daee
240-276-5744
danielle.daee@nih.gov
Epidemiology and Genomics Research, Healthcare Delivery Research, Cancer Survivorship Clinical Trials
Notice of Special Interest (NOSI): Alcohol and Cancer Control

Helpful Resources
NOT-CA-20-034 September 9, 2023 Tanya Agurs-Collins
240-276-6956
collinsta@nih.gov

David Berrigan
240-276-6752
berrigad@nih.gov
Health Behaviors Research
Notice of Special Interest (NOSI): Research on Oral Anticancer Agents in the Contexts of Utilization, Adherence, and Health Care Delivery NOT-CA-20-026 May 8, 2023 Wendy Nelson
240-276-6971
nelsonw@mail.nih.gov
Healthcare Delivery Research, Basic Biobehavioral and Psychological Sciences, Epidemiology and Genomics Research
Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers NOT-CA-20-022 January 8, 2023

Vaurice Starks
301-624-1299
starksv@mail.nih.gov

Mukesh Verma
240-276-6889
vermam@mail.nih.gov

Epidemiology and Genomics Research
Core Infrastructure Support for Cancer Epidemiology Cohorts PAR-20-136 U01 Clinical Trial Not Allowed November 10, 2022

Joanne Elena
240-276-6818
joanne.elena@nih.gov

Epidemiology and Genomics Research Not Clinical Trials
Native American Research Centers for Health (NARCH) PAR-20-125 S06 Clinical Trials Optional July 24, 2021 Shobha Srinivasan
240-276-6938
sriniva2@mail.nih.gov
Health Disparities Clinical Trials
Research Answers to National Cancer Institute's (NCI) Provocative Questions RFA-CA-20-004 Parent Announcement R01 Clinical Trial Optional November 18, 2020

Sean Hanlon
240-781-3310
sean.hanlon@nih.gov

Parent and Omnibus Funding Announcements, Epidemiology and Genomics Research, Health Behaviors Research, Healthcare Delivery Research Clinical Trials
NCI Small Grants Program for Cancer Research PAR-20-052 Parent Announcement R03 Clinical Trial Optional January 8, 2023 Research Program Contacts Parent and Omnibus Funding Announcements Clinical Trials
Modular R01s in Cancer Control and Population Sciences PAR-18-869 Parent Announcement R01 Clinical Trial Optional March 9, 2021 Scott Rogers
240-276-6932
rogerssc@mail.nih.gov
Parent and Omnibus Funding Announcements, Epidemiology and Genomics Research, Implementation Science Clinical Trials
Cancer Prevention and Control Clinical Trials Grant Program PAR-18-559 Parent Announcement R01 Clinical Trial Required January 8, 2021 Susan Czajkowski
240-276-5871
Susan.Czajkowski@nih.gov
Parent and Omnibus Funding Announcements, Implementation Science Clinical Trials
Academic Research Enhancement Award PA-18-343 Parent Announcement R15 Clinical Trial Required January 8, 2021 April Oh
240-276-6709
april.oh@nih.gov
Parent and Omnibus Funding Announcements Clinical Trials
NIH Research Project Grant PA-18-484 Parent Announcement Parent R01 Clinical Trial Not Allowed January 8, 2021 Research Program Contacts Parent and Omnibus Funding Announcements Clinical Trials
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization PAR-19-352 R01 Clinical Trial Optional September 8, 2022 Michelle Mollica
240-276-7621
mollicama@mail.nih.gov
Cancer Survivorship Clinical Trials
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization PAR-19-355 R21 Clinical Trial Optional September 8, 2022 Michelle Mollica
240-276-7621
mollicama@mail.nih.gov
Cancer Survivorship Clinical Trials
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival PAR-18-893 R01 Clinical Trial Optional September 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
Cancer Survivorship, Health Behaviors Research Clinical Trials
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival PAR-18-892 R21 Clinical Trial Optional September 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
Cancer Survivorship, Health Behaviors Research Clinical Trials
Notice of Special Interest (NOSI): Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations NOT-HG-20-010 October 5, 2023 Leah Mechanic
240-276-6847
mechanil@mail.nih.gov
Epidemiology and Genomics Research
Co-infection and Cancer PAR-20-061 R21 Clinical Trial Not Allowed January 8, 2023 Tram Kim Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Co-infection and Cancer PAR-20-062 R01 Clinical Trial Not Allowed January 8, 2023 Tram Kim Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Biology of Bladder Cancer PAR-19-184 R21 Clinical Trial Optional May 8, 2022 Tram Kim Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Biology of Bladder Cancer PAR-19-183 R01 Clinical Trial Optional May 8, 2022 Tram Kim Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies PAR-19-325 R01 Clinical Trial Optional February 12, 2022 Kelly Filipski
240-276-6841
Filipskikk@mail.nih.gov
Epidemiology and Genomics Research, Cancer Survivorship Clinical Trial
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity PA-19-112 R01 Clinical Trial Optional January 8, 2022 Nonniekaye Shelburne
240-276-6897
nshelburne@mail.nih.gov
Epidemiology and Genomics Research, Cancer Survivorship Clinical Trials
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity PA-19-111 R21 Clinical Trial Optional January 8, 2022 Nonniekaye Shelburne
240-276-6897
nshelburne@mail.nih.gov
Epidemiology and Genomics Research, Cancer Survivorship Clinical Trials
Notice of Special Interest (NOSI): Geospatial Approaches in Cancer Control and Population Sciences NOT-CA-20-004 January 8, 2022

April Oh
240-276-6709
ohay@mail.nih.gov

Zaria Tatalovich
240-276-6976
tatalovichzp@mail.nih.gov

Epidemiology and Genomics Research, Health Communication and Informatics Research
Notice of Special Interest (NOSI): Use of Biological Information to Understand How the Interplay of Environmental Exposures and Genes Influences Cancer Risk NOT-CA-20-002 January 8, 2022

Stefanie Nelson
240-276-6944
nelsons@mail.nih.gov

Epidemiology and Genomics Research Not Clinical Trials
Exploratory Grants in Cancer Epidemiology and Genomics Research PAR-19-277 R21 Clinical Trial Optional October 9, 2021 Mukesh Verma
240-276-6889
vermam@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Diet and Physical Activity Assessment Methodology PAR-18-857 R21
Clinical Trial Not Allowed September 8, 2021 Richard Troiano
240-276-6916
troianor@mail.nih.gov

Kirsten Herrick
240-276-5734
herrickka@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Diet and Physical Activity Assessment Methodology PA-18-856 R01 Clinical Trial Not Allowed September 8, 2021 Richard Troiano
240-276-6916
troianor@mail.nih.gov

Kirsten Herrick
240-276-5734
herrickka@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression Announcement Numbers PA-18-738 R01 Clinical Trial Optional May 8, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression Announcement Numbers PA-18-739 R21 Clinical Trial Optional May 8, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility PA-18-677 R01 Clinical Trial Not Allowed May 8, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility PA-18-678 R21 Clinical Trial Not Allowed May 8, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-18-317 UH2/UH3 Clinical Trial Not Allowed January 8, 2021 Mukesh Verma
240-276- 6889 vermam@mail.nih.gov

Rao Divi
240-276-6913
divir@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Early-life Factors and Cancer Development Later in Life PA-18-531 R03 Clinical Trial Not Allowed January 8, 2021 Somdat Mahabir
240-276-6941
Mahabir@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Early-life Factors and Cancer Development Later in Life PA-18-529 R01 Clinical Trial Not Allowed January 8, 2021 Somdat Mahabir
240-276-6941
Mahabir@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Early-life Factors and Cancer Development Later in Life PA-18-532 R21 Clinical Trial Not Allowed January 8, 2021 Somdat Mahabir
240-276-6941
Mahabir@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-18-310 UH3 Clinical Trial Not Allowed October 9, 2020 Mukesh Verma
240-276- 6889 vermam@mail.nih.gov

Rao Divi
240-276-6913
divir@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers RFA-CA-19-045 U2C Clinical Trial Optional October 31, 2020 Leah Mechanic
240-276-6847
NCI_PE-CGS@mail.nih.gov

Elizabeth Gillanders
240-276-6764
NCI_PE-CGS@mail.nih.gov

Wen-Ying Sylvia Chou

240-276-6954
NCI_PE-CGS@mail.nih.gov
Epidemiology and Genomics Research, Health Communication and Informatics Research Clinical Trials
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Grant Program PA-17-444 R01 September 8, 2020 Charlisse Caga-anan
240-276-6738
charlisse.caga-anan@nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Grant Program PA-17-446 R21 September 8, 2020 Charlisse Caga-anan
240-276-6738
charlisse.caga-anan@nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Grant Program PA-17-445 R03 September 8, 2020 Charlisse Caga-anan
240-276-6738
charlisse.caga-anan@nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes PA-17-239 R01 May 8, 2020 Melissa Rotunno
240-276-7245
rotunnom@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes PA-17-243 R21 May 8, 2020 Melissa Rotunno
240-276-7245
rotunnom@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Notice of Special Interest (NOSI): NCI's Research Interests to Improve Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment NOT-CA-19-059 January 8, 2022 Sallie J. Weaver
240-276-6254
sallie.weaver@nih.gov

Veronica Chollette
240-276-6969
cholletv@mail.nih.gov
Healthcare Delivery Research, Cancer Survivorship
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses PAR-19-136 R01 Clinical Trial Optional January 8, 2022 Ashley Wilder Smith
240-276-6714
smithas@mail.nih.gov
Healthcare Delivery Research, Cancer Survivorship Clinical Trials
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses PAR-19-153 R21 Clinical Trial Optional January 8, 2022 Ashley Wilder Smith
240-276-6714
smithas@mail.nih.gov
Healthcare Delivery Research, Cancer Survivorship Clinical Trials
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations PA-18-932 R01 Clinical Trial Optional January 8, 2022 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Healthcare Delivery Research, Implementation Science Clinical Trials
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer PA-18-492 R21 Clinical Trial Optional May 8, 2021 Gurvaneet Randhawa
240-276-6940
gurvaneet.randhawa@nih.gov
Healthcare Delivery Research, Cancer Survivorship, Implementation Science Clinical Trials
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer PA-18-493 R01 Clinical Trial Optional May 8, 2021 Gurvaneet Randhawa
240-276-6940
gurvaneet.randhawa@nih.gov
Healthcare Delivery Research, Cancer Survivorship, Implementation Science Clinical Trials
Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests PA-17-495 R01 Clinical Trial Optional January 8, 2021 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-19-360 R01 Clinical Trial Optional September 8, 2022 Sarah Kobrin
240-276-6931
kobrins@mail.nih.gov
Healthcare Delivery Research, Implementation Science Clinical Trials
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-19-359 R03 Clinical Trial Optional July 17, 2022 Sarah Kobrin
240-276-6931
kobrins@mail.nih.gov
Healthcare Delivery Research, Implementation Science Clinical Trials
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-19-358 R21 Clinical Trial Optional September 8, 2022 Sarah Kobrin
240-276-6931
kobrins@mail.nih.gov
Healthcare Delivery Research, Implementation Science Clinical Trials
Mechanisms of Disparities in Chronic Liver Diseases and Cancer PAR-20-088 R01 Clinical Trial Not Allowed April 2, 2022 Tram Kim Lam
240-276-6967
lamt@mail.nih.gov
Health Disparities, Epidemiology and Genomics Research Not Clinical Trials
Mechanisms of Disparities in Chronic Liver Diseases and Cancer PAR-20-081 R21 Clinical Trial Not Allowed April 2, 2022 Tram Kim Lam
240-276-6967
lamt@mail.nih.gov
Health Disparities, Epidemiology and Genomics Research Not Clinical Trials
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors PAR-19-018 R01 Clinical Trial Not Allowed March 5, 2021 Damali Martin
240-276-6746
martinda@mail.nih.gov
Health Disparities, Epidemiology and Genomics Research Not Clinical Trials
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors PAR-19-019 R21 Clinical Trial Not Allowed March 5, 2021 Damali Martin
240-276-6746
martinda@mail.nih.gov
Health Disparities, Epidemiology and Genomics Research Not Clinical Trials
Academic Research Enhancement Award PA-18-504 Parent R15 January 8, 2021 Shobha Srinivasan
240-276-6938
sriniva2@mail.nih.gov
Health Disparities Not Clinical Trials
Administrative Supplements to Support Cancer Disparity Collaborative Research PA-18-842 Clinical Trial Optional September 11, 2020 Damali Martin
240-276-6746
martinda@mail.nih.gov
Health Disparities, Epidemiology and Genomics Research Clinical Trials
Intervention Research to Improve Native American Health PAR-17-496 R01 August 15, 2020 Shobha Srinivasan
240-276-6938
sriniva2@mail.nih.gov
Health Disparities
Research to Improve Native American Health PAR-17-464 R21 Clinical Trials Optional August 15, 2020 Shobha Srinivasan
240-276-6938
sriniva2@mail.nih.gov
Health Disparities Clinical Trials
Notice of Special Interest (NOSI): De-implementation of Ineffective or Low-value Clinical Practices along the Cancer Care Continuum NOT-CA-20-021 May 10, 2022 Erica Breslau
240-276-6773
breslaue@mail.nih.gov

Wynne E. Norton
240-276-6875
wynne.norton@nih.gov
Implementation Science
Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity) PAR-19-274 R01 Clinical Trial Optional May 8, 2022 Gila Neta
240-276-6785
netagil@mail.nih.gov

Cynthia A. Vinson
240-276-6745
cvinson@mail.nih.gov
Implementation Science Clinical Trials
Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity) PAR-19-275 R21 Clinical Trial Optional May 8, 2022 Gila Neta
240-276-6785
netagil@mail.nih.gov

Cynthia A. Vinson
240-276-6745
cvinson@mail.nih.gov
Implementation Science Clinical Trials
Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity) PAR-19-276 R03 May 8, 2022 Gila Neta
240-276-6785
netagil@mail.nih.gov

Cynthia A. Vinson
240-276-6745
cvinson@mail.nih.gov
Implementation Science Not Clinical Trials
Integration of Individual Residential Histories into Cancer Research PA-17-298 R01 September 8, 2020 Zaria Tatalovich
240-276-6976
tatalovichzp@mail.nih.gov
Surveillance Research Not Clinical Trials
Integration of Individual Residential Histories into Cancer Research PA-17-295 R21 September 8, 2020 Zaria Tatalovich
240-276-6976
tatalovichzp@mail.nih.gov
Surveillance Research Not Clinical Trials
Leveraging Population-based Cancer Registry Data to Study Health Disparities PA-17-289 R01 September 8, 2020 Nadia Howlader
240-276-6891
howladern@mail.nih.gov
Surveillance Research Not Clinical Trials
Leveraging Population-based Cancer Registry Data to Study Health Disparities PA-17-288 R21 September 8, 2020 Nadia Howlader
240-276-6891
howladern@mail.nih.gov
Surveillance Research Not Clinical Trials
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control PAR-20-034 R01 Clinical Trial Optional January 8, 2023 Rebecca Ferrer
301-852-1167
rebecca.ferrer@nih.gov
Basic Biobehavioral and Psychological Sciences Clinical Trials
Perception and Cognition Research to Inform Cancer Image Interpretation PAR-19-387 R01 Clinical Trial Optional January 8, 2023 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
Basic Biobehavioral and Psychological Sciences Clinical Trials
Perception and Cognition Research to Inform Cancer Image Interpretation PAR-19-389 R21 Clinical Trial Optional January 8, 2023 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
Basic Biobehavioral and Psychological Sciences Clinical Trials
Neural Regulation of Cancer PAR-19-353 R01 Clinical Trial Not Allowed May 28, 2022 Chamelli Jhappan
jhappanc@mail.nih.gov

Paige Green
240-276-6899
paige.green@nih.gov
Basic Biobehavioral and Psychological Sciences Not Clinical Trials
Neural Regulation of Cancer PAR-19-354 R21 Clinical Trial Not Allowed May 28, 2022 Chamelli Jhappan
jhappanc@mail.nih.gov

Paige Green
240-276-6899
paige.green@nih.gov
Basic Biobehavioral and Psychological Sciences Not Clinical Trials
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment PAR-19-340 R01 Clinical Trial Optional June 9, 2022 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
Basic Biobehavioral and Psychological Sciences, Cancer Survivorship Clinical Trials
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment PAR-19-339 R21 Clinical Trial Optional June 9, 2022 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
Basic Biobehavioral and Psychological Sciences, Cancer Survivorship Clinical Trials
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery PAR-19-373 R01 Clinical Trials Not Allowed March 18, 2021 Rebecca Ferrer
301-852-1167
rebecca.ferrer@nih.gov
Basic Biobehavioral and Psychological Sciences Not Clinical Trials
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery PAR-19-384 R01 Basic Experimental Studies with Humans Required March 18, 2021 Rebecca Ferrer
301-852-1167
rebecca.ferrer@nih.gov
Basic Biobehavioral and Psychological Sciences Clinical Trials
Notice of Additional Due Date and Additional “Areas of Focus Especially of Interest” of PAR-19-373 and PAR-19-384, "Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)" NOT-OD-20-103     March 18, 2021 Rebecca Ferrer
301-852-1167
rebecca.ferrer@nih.gov
Basic Biobehavioral and Psychological Sciences
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control PAR-19-309 R21 Clinical Trial Optional September 8, 2022 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov
Health Behaviors Research, Implementation Science Clinical Trials
Time-Sensitive Obesity Policy and Program Evaluation PAR-18-854 R01 September 11, 2021 David Berrigan
240-276-6752
David.Berrigan@nih.gov

Jill Reedy
240-276-6812
reedyj@mail.nih.gov
Health Behaviors Research, Epidemiology and Genomics Research Not Clinical Trials
Exploratory/Developmental Clinical Research Grants in Obesity PA-18-720 R21 Clinical Trial Optional May 8, 2021 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov 
Health Behaviors Research Clinical Trials
Testing Interventions for Health-Enhancing Physical Activity PAR-18-324 R01 Clinical Trial Optional January 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
Health Behaviors Research Clinical Trials
Testing Interventions for Health-Enhancing Physical Activity PAR-18-307 R21/R33 Clinical Trial Optional January 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
Health Behaviors Research Clinical Trials
Notice of Special Interest (NOSI): Smart and Connected Health (National Science Foundation – NIH Interagency Initiative) NOT-OD-13-041 April Oh
240-276-6709
april.oh@nih.gov
Health Communication and Informatics Research Not Clinical Trials
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness PA-18-498 R01 Clinical Trial Optional May 8, 2021 Sylvia Chou
240-276-6954
chouws@mail.nih.gov
Health Communication and Informatics Research, Cancer Survivorship Clinical Trials
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness PA-18-499 R21 Clinical Trial Optional May 8, 2021 Sylvia Chou
240-276-6954
chouws@mail.nih.gov
Health Communication and Informatics Research, Cancer Survivorship Clinical Trials
Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities PAR-19-093 R01 Clinical Trial Optional March 5, 2021 April Oh
240-276-6709
april.oh@nih.gov
Health Communication and Informatics Research, Implementation Science Clinical Trials
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem PAR-19-348 R01 Clinical Trial Optional June 9, 2022 Kelly Blake
240-281-5934
kelly.blake@nih.gov
Health Communication and Informatics Research Clinical Trials
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem PAR-19-350 R21 Clinical Trial Optional June 9, 2022 Kelly Blake
240-281-5934
kelly.blake@nih.gov
Health Communication and Informatics Research Clinical Trials
Pathway to Independence Award in Tobacco Regulatory Research RFA-OD-20-010 K99/R00 Independent Clinical Trial Required July 11, 2022 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Tobacco Control Research Clinical Trials
Pathway to Independence Award in Tobacco Regulatory Research RFA-OD-20-009 K99/R00 Independent Clinical Trial Not Allowed July 11, 2022 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Tobacco Control Research Not Clinical Trials
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research RFA-OD-20-011 K01 Independent Clinical Trial Required July 11, 2022 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Tobacco Control Research Clinical Trials
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research RFA-OD-20-008 K01 Independent Clinical Trial Not Allowed July 11, 2022 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Tobacco Control Research Not Clinical Trials
Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments NOT-CA-20-025 May 8, 2022 Mark Parascandola
240-276-6871
paramark@mail.nih.gov
Tobacco Control Research, Health Behaviors Research, Health Disparities, Implementation Science
Mechanism for Time-Sensitive Drug Abuse Research PAR-19-064 R21 Clinical Trial Optional November 9, 2021 Kelly Blake
240-281-5934
kelly.blake@nih.gov
Tobacco Control Research, Health Communication and Informatics Research Clinical Trials
Notice of Special Interest (NOSI): Mechanism for Time-Sensitive Drug Abuse Research NOT-CA-19-015 November 9, 2021 Kelly Blake
240-281-5934
kelly.blake@nih.gov
Tobacco Control Research, Health Communication and Informatics Research Not Clinical Trials
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study PAR-19-162 R01 Clinical Trial Not Allowed September 8, 2021 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Tobacco Control Research Not Clinical Trials
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study PAR-19-163 R21 Clinical Trial Not Allowed September 8, 2021 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Tobacco Control Research Not Clinical Trials
Tobacco Regulatory Science RFA-OD-19-028 R01 Clinical Trial Optional February 14, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Tobacco Control Research Clinical Trials
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services PAR-18-222 R01 Clinical Trial Optional November 14, 2020 Michele Bloch
240-276-6878
blochm@mail.nih.gov
Tobacco Control Research, Implementation Science Clinical Trials
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services PAR-16-455 R01 November 14, 2020 Michele Bloch
240-276-6878
blochm@mail.nih.gov
Tobacco Control Research, Implementation Science Not Clinical Trials
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research PAR-18-847 R01 Clinical Trial Optional June 28, 2020 For cancer-related FOA questions:
Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov

For general FOA questions:
Dionne Godette-Greer
Office of Disease Prevention (ODP)
301-480-1161
dionne.godette@nih.gov
Tobacco Control Research Clinical Trials
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research PAR-18-848 R21 Clinical Trial Optional June 28, 2020 For cancer-related FOA questions:
Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov

For general FOA questions:
Dionne Godette-Greer
Office of Disease Prevention (ODP)
301-480-1161
dionne.godette@nih.gov
Tobacco Control Research Clinical Trials
U.S. Tobacco Control Policies to Reduce Health Disparities PAR-18-675 R01 Clinical Trial Optional June 16, 2020 Bob Vollinger
240-276-6919
Bob.Vollinger@nih.gov

Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Tobacco Control Research, Implementation Science Clinical Trials
U.S. Tobacco Control Policies to Reduce Health Disparities PAR-18-674 R21 Clinical Trial Optional June 16, 2020 Bob Vollinger
240-276-6919
Bob.Vollinger@nih.gov

Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Tobacco Control Research, Implementation Science Clinical Trials
Maximizing the Scientific Value of Existing Biospecimen Collections RFA-OD-19-021 R21 Clinical Trial Not Allowed March 9, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Tobacco Control Research Not Clinical Trials
Secondary Analyses of Existing Datasets of Tobacco Use and Health RFA-OD-19-022 R21 Clinical Trial Not Allowed March 9, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Tobacco Control Research Not Clinical Trials

 

Go to the Archive of Funding Opportunities for information on recent funding announcements. Visit the Cancer Control Research section of this website for descriptive information on currently funded grants in this area.